Pharmagate® is a support in the regulatory strategy framework at different stages of medical use products life cycle.
The company supports and helps to manage access to the market on territories in the following regions –
• Russia • Ukraine • Belarus • Moldova • Georgia • Armenia
• Azerbaijan • Kazakhstan • Kyrgyzstan • Turkmenistan • Tajikistan
• Uzbekistan • Mongolia
www.pharmagate.co.uk/en/
QuintilesIMS (NYSE:Q) is a leading integrated information and technology-enabled healthcare service provider worldwide, dedicated to helping its clients improve their clinical, scientific and commercial results. Formed through the merger of Quintiles Transnational and IMS Health, QuintilesIMS’s approximately 50,000 employees conduct operations in more than 100 countries. Companies seeking to improve real-world patient outcomes through treatment innovations, care provision and access can leverage QuintilesIMS’s broad range of healthcare information, technology and service solutions to drive new insights and approaches. QuintilesIMS provides solutions that span clinical to commercial, bringing customers a unique opportunity to realize the full potential of innovations and advanced healthcare outcomes.
As a global leader in protecting individual patient privacy, QuintilesIMS uses healthcare data to deliver critical, real-world disease and treatment insights. Through a wide variety of privacy-enhancing technologies and safeguards, QuintilesIMS protects individual privacy while managing information to drive healthcare forward. These insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders in the development and approval of new therapies, and to identify unmet treatment needs and understand the safety, effectiveness and value of pharmaceutical products in improving overall health outcomes. To learn more, visit www.QuintilesIMS.com
Here at Viseven we know how to run a digital marathon and reach highest business goals with Digital Content Factory – a new type of cooperation between Global Marketing Team, Local Teams and Digital Agencies.
Empower marketing and commercial teams to tackle the digitalization challenge and ensure maximum profitability.
Solve the scalability challenges with a platform that supports decentralized execution with centralized governance.
Reduce costs and drive efficiency by standardizing the processes, based on eWizard platform, which enables easy skillset adoption, likewise content and components reuse. Save time and budget for email templates creation, mobile apps and eDetailing development, localization and distribution to quickly respond to any market changes.
Legalmax is recognized as one of the leading law firms specializing in the provision of legal services on key issues related to the registration and protection of intellectual property in the Russian-speaking countries of the CIS. With offices in Uzbekistan and Kazakhstan, Legalmax offers a wide range of legal services related to the registration of trademarks, patens and other areas of intellectual property and is closely associated with pharmaceutical industry. Moreover, Legalmax specializes in challenging and protection of intellectual property rights, suppression of unfair competition and protection from counterfeiting, IP-monitoring and other legal services.
Established in 1994. The Association comprises 60 international pharmaceutical companies that provide over 80% of the world’s pharmaceutical products and over 60% of medicines imported to the Russian Federation.
AIPM Mission
To promote economic and legal policies that focus on the development of organized and open pharmaceutical market, improving of medical services quality and expansion of the range of modern medicines for the benefit of Russian people.
http://www.en.arfp.ru/
http://spfo.ru/
http://sojuzpharma.ru/
”Pharmvestnik” (Pharmaceutical Bulletin) is the leading specialized weekly newspaper covering the Russian pharmaceutical industry with a certified circulation of 16 200 copies. The 20 year-long first-hand pharma market experience has made it a reliable source of professional information for all types of market players – manufacturers, distributors, pharmacies, regulators – as well as the pharmaceutical and medical communities at large.
”Pharmvestnik” carries opinions of market leaders, leading experts, authorities, and public organizations.
It covers the Russian pharma market analysis by sector, regulatory activities as well as offers practical advice valuable in the pharmacist’s and HR manager’s perspective. Equal coverage is also given to all Russia’s federal districts as ”Pharmvestnik” has regional representatives in all largest cities and towns.
Since 2013, the “PhV-Analytics” series has been published under ”Pharmvestnik” umbrella brand. It includes a digital quarterly collection of analytical reports on all aspects of the pharma market functioning and a hard-copy annual report.
Depharm.net — the search service of manufacturers & suppliers, offers you an international platform with the latest updated base of companies that supply quality equipment, products and services in the pharmaceutical and medical industries.
Key information achievements:
▪ easy catalogue of manufacturers & suppliers
▪ major industry events: exhibitions, seminars, conferences, forums
▪ main news of the national and world scale
▪ online release of annual Russian language printed edition «Handbook of a pharmaceutical worker».
* Annual reference information edition for TOP-managers of enterprises, technical experts and purchasing department, which spread by way personal address delivered to all leading enterprises of a given industry.
Remedium group of Companies renders the whole range of services for specialists in the field of medicine and pharmaceutics. For years the principle directions of activity of “Remedium” Group of Companies are publication of particularized periodicals, assignment of electronic databases, arrangement and implementation of measures, rent-a-rep service, organization of advertisement and PR support.
http://gmpnews.ru/
Research and production reviewed journal "Drug Development & Registration" is actual free applied edition for the pharmaceutical experts.
Companies and their employees from production, development, research, quality control and registration departments; staff of the laboratories, contract research organizations, scientific and educational centers and universities are our target audience. Now the journal has more than 16 000 subscribers. Publications are distributed at all key pharmaceutical, chemical and technological actions (seminars, conferences and exhibitions). The journal is read and discussed in all cities of Russia. There are residents in Russia, CIS and Europe among subscribers of journal.
Four main subject parts of the journal "Drug Development & Registration" include drug development cycle from its synthesis till getting drug registration certificate. The first part is devoted to pharmaceutical technology and surveys the scientific and practical issues from extraction and production of pharmaceutical substances, technologies and equipment to standard medical products manufacture; the subject of the second part is the study of analytical procedure of quality control; the third examines approaches to the drug quality and safety evaluation and the fourth part describes questions regarding validation of methods, preparing registration data and drug life cycle in GxP environment.
https://www.pharm.reviews
http://vrachivmeste.ru
www.farmsouz.ru
Yellmed - is:
Yellmed - all about Russian medicine and more!
http://pharmnews.kz/
http://www.con-med.ru/
http://www.medsovet.info/
http://promoboz.com/ru
http://www.probusinesstv.ru/
http://lekoboz.ru/